Prostate Cancer screening blood test uses a combination PSA and epigenetic markers to improve accuracy and reduce false positive results. Further evaluation in larger population cohorts recommended by study authors.

Dr. Barry Dworkin

Medical Mythbusting Commentary for February 14, 2023

Prostate Cancer screening blood test uses a combination PSA and epigenetic markers to improve accuracy and reduce false positive results. Further evaluation in larger population cohorts recommended by study authors. Play Now | Play in Popup | Download

Source:
New blood test may be 94 per cent effective at spotting signs of prostate cancer

Reference:
Circulating Chromosome Conformation Signatures Significantly Enhance PSA Positive Predicting Value and Overall Accuracy for Prostate Cancer Detection

Related posts:

  1. Cancer Care Ontario advises against prostate cancer screening with PSA test
  2. Repeating PSA test reduces number of unnecessary biopsies
  3. "New" PSA guidelines from Prostate Cancer Canada will cause more harm than good and is not supported by evidence
  4. Study to compare MRI vs PSA screening for prostate cancer. It will not be able to answer if it improves survival
Bitnami